ArticleThe Journal of clinical endocrinology and metabolism2026
Pathogenesis of Noonan Syndrome is Modulated by NOC2L, a Novel Interactor of LZTR1 Leading to Impaired P53 Signalling.
Sumana Chatterjee et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.